CD8A and tuberculosis: This indicated that BCG-Nanocage not only preserved the ability of BCG to induce responses of Th1/Th1-like cells and CD8+ cytotoxic cells but also make the anti-TB immune responses more potent or broader through engineering BCG-Nanocage from clumped-clustered features BCG to more uniform nanoparticles.